Durysta is administered by a qualified healthcare provider as an eye injection into the eye. Here below is how treatment is administered:

• Professional Management: An eye care professional administers Durysta into the eye in an office setting that is sterile. The injection is commonly administered in the office and takes only a few minutes.
• No Morning and Evening Dosage: Unlike eye drops, Durysta is a once-and-done treatment that lasts for about 4 months, providing relief of enhanced intraocular pressure all day
• Follow-Up Visits: You will need to have follow-up visits from time to time following the injection to monitor your intraocular pressure and whether the medicine is working properly or not.

• Durysta replicates the action of a naturally occurring substance found in the eye. It enables the drainage of fluid (aqueous humor) out of the interior of the eye and, in the process, reduces the intraocular pressure. Increased intraocular pressure is the primary risk factor for glaucoma because it tends to lead to optic nerve damage, which conducts visual information from the eye to the brain.
• The active ingredient of Durysta, bimatoprost, increases drainage of fluid by a specific pathway in the eye called the trabecular meshwork and thus decreases intraocular pressure. This prevents further damage to the optic nerve, which is critical in preventing blindness.

Similar to all drugs, Durysta does have side effects, but not everyone will get them. Frequent and also harmful side effects of Durysta are:

Common Side Effects:

• Redness of the eye
• Irritation of the eye
• Blurry vision
• Discomfort or dryness in the eye
• Foreign body sensation (something in the eye)

Severe Side Effects:

• Eye Infection: Each injection carries a risk of infection, but it is not with Durysta. Notify your doctor if you notice unusual discomfort, swelling, or eye discharge.
• Increased Eye Pressure: While Durysta decreases intraocular pressure, in extremely rare cases, it may increase eye pressure momentarily after injection.
• Eye Color Changes: Bimatoprost, the active substance in Durysta, may lead to a color change in the eyes over time, especially in patients with lighter-colored eyes (blue, green, or gray).
• Vision Changes: Sudden change in vision, eye pain, or eye discomfort are signs that need immediate medical attention.

Before getting Durysta, the following are some important warnings and precautions to keep in mind:

• Eye Diseases: If you have a past history of eye infection, inflammation, or any other eye disease, tell your doctor. Durysta can be contraindicated in patients with certain underlying eye conditions.
• Pregnancy and Lactation: Durysta is not employed during pregnancy only when the risk is outweighed by the benefit. Tell your doctor if you are pregnant or lactating prior to administration of Durysta.
• Risk of Infection: Since Durysta is an injectable drug, risk of infection from the injection site is low. Your doctor will also go out of his way to reduce this risk by using proper hygiene and aseptic procedures.
• Other Health Conditions: If you have a systemic illness (e.g., heart disease, liver or kidney disease) that may affect treatment with Durysta, tell your doctor before initiating therapy with Durysta.

• Other Eye Medications: Inform your eye doctor if you take any other medication for eye diseases. Even though Durysta is for lowering elevated eye pressure, taking it with other medications for the eye may need to be closely monitored.
• Other Prostaglandin Analogues: Do not use other prostaglandin analogues like latanoprost or travoprost in the same eye when using Durysta unless your eye doctor instructs you to.
• Systemic Medications: Even though Durysta only affects the eye, it is best that you inform your doctor if you are currently taking any other systemic medication like for heart disease, diabetes, or for high blood pressure to avoid any potential interactions.

The therapy with Durysta is typically one injection of 10 mcg into the eye. The medication is designed to be long-acting, reducing intraocular pressure for as much as 4 months.

 Your eye physician will determine the particular timing and frequency of treatment based on your condition.

Durysta is a prescription drug, therefore only a qualified doctor can prescribe it. It should only be administered in a physician’s office by a competent individual. Your doctor will evaluate your case and determine whether Durysta is suitable for you.

 Make sure to follow up regularly to maintain the drug’s effectiveness and watch out for any potential side effects.

• What is Durysta?
  Durysta is an eye implant that helps lower eye pressure in patients with glaucoma or ocular hypertension.

• How does Durysta work?
  It slowly releases bimatoprost, which increases fluid outflow from the eye, reducing intraocular pressure (IOP).

• Who is Durysta for?
  It’s used in adults with open-angle glaucoma or ocular hypertension who need long-term pressure control.

• How is Durysta administered?
  It is a tiny implant injected directly into the eye by an eye care professional.

• How long does a Durysta implant last?
  Typically around 3–4 months, though effects may last longer in some patients.

• Is Durysta a one-time treatment?
  No, additional implants may be needed, but repeat implantation in the same eye is limited.

• What are the benefits of Durysta over eye drops?
  It provides continuous drug delivery without needing daily dosing.

• What are the common side effects of Durysta?
  Eye redness, foreign body sensation, blurry vision, and light sensitivity.

• Are there serious risks with Durysta?
  Potential risks include corneal endothelial cell loss and implant-related complications.

• Who should not use Durysta?
  Patients with corneal endothelial cell problems, prior corneal transplant, or certain eye infections.

• Is Durysta permanent?
  No, the implant dissolves over time after releasing the medication.

• Can Durysta be used in both eyes?
  Yes, but treatment is determined by the doctor based on the patient’s needs.

• Does Durysta replace glaucoma surgery?
  Not necessarily—it’s an alternative or complement to other treatments.

• Can Durysta lower eye pressure better than drops?
  It is effective, but results vary; some patients may still need additional therapy.

• Does insurance cover Durysta?
  Many insurance plans, including Medicare, may cover it depending on eligibility.

• Is Durysta FDA-approved?
  Yes, Durysta was FDA-approved in March 2020.

• Can Durysta be removed if needed?
  Yes, an ophthalmologist can remove the implant if necessary.

• Is Durysta safe for long-term use?
  Long-term safety is being studied; repeat use may increase certain risks.

• Does Durysta affect eye color like some glaucoma drops?
  Yes, like bimatoprost drops, it may darken iris or eyelid pigmentation.

• When should I ask my doctor about Durysta?
  If you struggle with daily eye drops or need better eye pressure control.